Notice of Intent to Sole Source – Lease of Avatar™ Odyssey Instruments (Xcell Biosciences)

The National Institutes of Health (NIH) intends to award a firm-fixed-price contract on a sole source basis to Xcell Biosciences, Inc. for the lease of four Avatar Odyssey instruments. The instruments will be used to support process development activities within the Center for Cellular Engineering (CCE) laboratories located at the NIH Clinical Center, Bethesda, Maryland. The lease period will be for six months. The Avatar Odyssey platform is the only commercially available system that integrates programmable control of both oxygen tension and pressure within a single system suitable for cell therapy process development. • The contract is for the lease of four Avatar Odyssey instruments. • The lease period is for six months. • The instruments will be used for process development activities within the CCE laboratories. • The Avatar Odyssey platform is the only commercially available system that meets the requirements. • Interested parties may submit a capability statement demonstrating their ability to meet this requirement.